Expert perspectives on incorporating glucagon-like peptide-1 receptor agonist in diabetes and chronic kidney disease: challenges and opportunities.

Halimi JM, Fauchier L, Karras A, Amouyal C, Eladari D, Rossignol P, Choukroun G, Zaoui P, Girerd N, Hadjadj S

DOI: 10.1093/eurjpc/zwaf426
Published: 2026 Jan 6
Container: European journal of preventive cardiology
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1093/eurjpc/zwaf426,
  title = {Expert perspectives on incorporating glucagon-like peptide-1 receptor agonist in diabetes and chronic kidney disease: challenges and opportunities.},
  author = {Halimi JM and Fauchier L and Karras A and Amouyal C and Eladari D and Rossignol P and Choukroun G and Zaoui P and Girerd N and Hadjadj S},
  year = {2026},
  journal = {European journal of preventive cardiology},
  doi = {10.1093/eurjpc/zwaf426},
  url = {https://doi.org/10.1093/eurjpc/zwaf426}
}

RIS

TY  - JOUR
TI  - Expert perspectives on incorporating glucagon-like peptide-1 receptor agonist in diabetes and chronic kidney disease: challenges and opportunities.
AU  - Halimi JM
AU  - Fauchier L
AU  - Karras A
AU  - Amouyal C
AU  - Eladari D
AU  - Rossignol P
AU  - Choukroun G
AU  - Zaoui P
AU  - Girerd N
AU  - Hadjadj S
PY  - 2026
JO  - European journal of preventive cardiology
DO  - 10.1093/eurjpc/zwaf426
UR  - https://doi.org/10.1093/eurjpc/zwaf426
ER  -

APA

JM, H., L, F., A, K., C, A., D, E., P, R., G, C., P, Z., N, G., & S, H. (2026). Expert perspectives on incorporating glucagon-like peptide-1 receptor agonist in diabetes and chronic kidney disease: challenges and opportunities.. European journal of preventive cardiology. https://doi.org/10.1093/eurjpc/zwaf426

Source records

pubmed · retrieved 2026-09-26T11:05:08.365Z